Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Community-Acquired Pneumonia: lytA TArgeted Real Time Quantitative Polymerase chaIN Reaction for Improved Detection of Pneumococci (CAPTAIN)

NCT03315403 is registered in ClinicalTrials.gov with Medical Center Alkmaar as lead sponsor.

NCT NCT03315403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03315403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Community-Acquired Pneumonia: lytA TArgeted Real Time Quantitative Polymerase chaIN Reaction for Improved Detection of Pneumococci (CAPTAIN)
Lead sponsor
Medical Center Alkmaar
Phase
Observational
Overall status
Completed
Start date
April 5, 2018
Completion date
March 12, 2020
Enrollment
922 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

community-acquired pneumonia, pneumonia, pneumococcal